Sun Pharma Wins FDA Approval for ILUMYA in Psoriatic Arthritis
The approval expands ILUMYA’s use beyond plaque psoriasis, adding a treatment option for adults with active psoriatic arthritis.
Related stories
UK Regulator Warns Car Lenders Over Low Compensation Offers
L impact | REGULATION | Nov 03, 2026, 09:19 AM UTC
FCA Sets Expectations for Firms Making Car Finance Settlement Offers
The UK Financial Conduct Authority set expectations for firms making car finance settlement offers.
L impact | REGULATION | Nov 03, 2026, 09:19 AM UTC
EU Court Adviser Says AI Chatbot Use May Infringe Press Publishers’ Rights
L impact | REGULATION | Nov 03, 2026, 09:17 AM UTC
Spain Readies Emergency Aid for Rail Crash Victims
Spain is preparing an emergency aid package for victims and families of last week’s high-speed train collision. Transport Minister Oscar Puente is due to face lawmakers’ questions
M impact | REGULATION | Nov 03, 2026, 09:10 AM UTC
Former China Eastern Airlines Chairman Liu Shaoyong Sentenced to 14 Years
State media reported that former China Eastern Airlines chairman Liu Shaoyong was sentenced to 14 years in prison.
L impact | REGULATION | Nov 03, 2026, 09:02 AM UTC
Pinming Tech Says Controller Mo Xujun Probed by Securities Regulator
Pinming Tech says its actual controller, Mo Xujun, is under investigation by a securities regulator over suspected market manipulation.
M impact | REGULATION | Nov 03, 2026, 08:48 AM UTC